Remove Branding Remove Clinical Trials Remove Pharma Companies
article thumbnail

DoP releases new UCPMP for pharma and medical devices companies

AuroBlog - Aurous Healthcare Clinical Trials blog

The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.

article thumbnail

Biogen continues to sink

World of DTC Marketing

At 99% of pharma companies, that's a huge no-no. On top of this, “the company also revealed that the Federal Trade Commission and the Securities and Exchange Commission had opened two new, separate investigations into the troubled biotech. At 99% of pharma companies, that’s a huge no-no.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Value of PPC Campaigns in Modern Pharma Marketing

Pharma Marketing Network

In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Gone are the days when print ads and in-person detailing alone could carry a brand. Moreover, PPC isnt just about Google Ads.

article thumbnail

Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict

Pharmaceutical Technology

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact.

article thumbnail

Lilly has a new blockbuster

World of DTC Marketing

The drug led to impressive blood sugar and body weight drops in clinical trials. The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes. Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. A matter of trust?

Drugs 218
article thumbnail

Communicating with HCPs via email

World of DTC Marketing

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. Your physician audience should be segmented by parameters that are important to the success of your brand.

Doctors 180
article thumbnail

Content Marketing Campaigns: How Pharma Brands Engage HCPs & Patients

Pharma Marketing Network

Introduction In todays digital-first world, content marketing campaigns are no longer optional for pharmaceutical brands. Imagine content marketing as the heartbeat of a pharma brands digital presence. So, how can pharma companies use content marketing to engage HCPs and patients effectively ? Lets dive in.